Terumo Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Terumo Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11703
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Terumo Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Terumo Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Terumo Corporation (Terumo or ‘the company’) is a provider of medical equipment and services. It is engaged in developing, manufacturing, marketing and distributing medical devices across the world. The company’s product portfolio includes infusion systems , blood transfusion systems, cardiovascular surgical systems , diabetes monitoring, artificial vascular grafts, vascular interventional products, nutritious food and treatment devices, home oxygen therapy systems and consumer healthcare products cancer pain management systems. The company’s systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo It also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients, which are used to collect and transfuse blood. The company along with its subsidiaries and affiliates operates across Japan, and Asia (excluding China and Japan), Europe, China, North America and South America. It is headquartered in Tokyo, Japan.

Scope

- Detailed information on Terumo Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Terumo Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Terumo Corporation including a breakdown and examination of key business segments
- Intelligence on Terumo Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Terumo Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Terumo Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Terumo Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Terumo Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Terumo Corporation: Company Overview 9
Terumo Corporation: Overview and Key Facts 9
Terumo Corporation: Overview 9
Terumo Corporation: Key Facts 9
Terumo Corporation: Key Employees 11
Terumo Corporation: Key Employee Biographies 13
Terumo Corporation: Major Products and Services 16
Terumo Corporation: Company History 17
Terumo Corporation: Management Statement 23
Terumo Corporation: Locations and Subsidiaries 27
Terumo Corporation: Key Competitors 29
Terumo Corporation: Company Analysis 30
Terumo Corporation: Business Description 30
Terumo Corporation: SWOT Analysis 31
Terumo Corporation: SWOT Overview 31
Terumo Corporation: Strengths 31
Terumo Corporation: Weaknesses 32
Terumo Corporation: Opportunities 33
Terumo Corporation: Threats 33
Terumo Corporation: Corporate Financial Deals Activity 35
Terumo Corporation: Financial Deals Overview 35
Terumo Corporation: Targets and Partners 37
Terumo Corporation: Top Deals 2014 – 2018YTD* 38
Terumo Corporation: Mergers and Acquisitions 39
Terumo Corporation: Corporate Venturing 40
Terumo Corporation: Partnership 41
Terumo Corporation: Recent Developments 42
Terumo Corporation: News and Events Summary 42
Terumo Corporation: Business Expansion 45
Terumo Corporation: Contracts 46
Terumo Corporation: Corporate Governance 47
Terumo Corporation: Market Developments 48
Terumo Corporation: Regulatory and Legal Events 48
Terumo Corporation: Strategy and Operations 48
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: Terumo Corporation: Key Facts
Table 2: Terumo Corporation: Key Employees
Table 3: Terumo Corporation: Company History
Table 4: Terumo Corporation: Locations and Subsidiaries
Table 5: Terumo Corporation: Key Competitors
Table 6: Terumo Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Terumo Corporation: M&A Activity by Geography (TTM*)
Table 8: Terumo Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Terumo Corporation: M&A Average Deal Size - Value (US$m)
Table 10: Terumo Corporation: Targets and Partners
Table 11: Terumo Corporation: Top Deals 2014 - 2018YTD*
Table 12: Terumo Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Terumo Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Terumo Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Terumo Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Terumo Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Terumo Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Terumo Corporation: News and Events Summary
Table 19: Terumo Corporation: Business Expansion
Table 20: Terumo Corporation: Contracts
Table 21: Terumo Corporation: Corporate Governance
Table 22: Terumo Corporation: Market Developments
Table 23: Terumo Corporation: Regulatory and Legal Events
Table 24: Terumo Corporation: Strategy and Operations

List of Figures
Figure 1: Terumo Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Terumo Corporation: M&A Activity by Geography (TTM*)
Figure 3: Terumo Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Terumo Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: Terumo Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Terumo Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Terumo Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Terumo Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Terumo Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Terumo Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Terumo Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Modec Inc (6269):企業の財務・戦略的SWOT分析
    Modec Inc (6269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aon plc:戦略・SWOT・企業財務分析
    Aon plc - Strategy, SWOT and Corporate Finance Report Summary Aon plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Somnomed Ltd (SOM):企業の財務・戦略的SWOT分析
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • Outlook Therapeutics Inc (ONSIU):企業の財務・戦略的SWOT分析
    Summary Outlook Therapeutics Inc (Outlook Therapeutics), formerly Oncobiologics Inc, is a biopharmaceutical company that develops, manufactures and commercializes biosimilar products in the areas of ophthalmology. The company is investigating its lead product candidate, ONS-5010 an ophthalmic formul …
  • Aptitude Medical Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aptitude Medical Systems Inc (Aptitude Medical) is a developer of dynamic proteins, lipids, sugars and metabolites. The company's target range comprises nonimmunogenic proteins, peptides, toxins, glycans, drugs, metabolites and small epitopes. Its integrated suite of proprietary technologies …
  • Epax Norway AS:企業の戦略・SWOT・財務情報
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • Development Bank of Southern Africa:電力:M&Aディール及び事業提携情報
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Scancell Holdings Plc (SCLP)-製薬・医療分野:企業M&A・提携分析
    Summary Scancell Holdings Plc (Scancell) is a pharmaceutical company that develops, manufactures and markets cancer vaccines. The company develops products that stimulate the immune system to treat or prevent cancer. It offers SCIB1, a cancer vaccine that is used in the treatment of melanoma. Scance …
  • Micell Technologies Inc:企業の製品パイプライン分析2018
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務分析
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • LifeScan Inc-医療機器分野:企業M&A・提携分析
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Svenska Cellulosa AB:戦略・SWOT・企業財務分析
    Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lamb Weston Holdings, Inc. (LW):企業の財務・戦略的SWOT分析
    Lamb Weston Holdings, Inc. (LW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Boparan Holdings Ltd:企業の戦略的SWOT分析
    Boparan Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Fidelity National Information Services, Inc.:企業のM&A・事業提携・投資動向
    Fidelity National Information Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fidelity National Information Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Seaboard Corp (SEB):企業の財務・戦略的SWOT分析
    Seaboard Corp (SEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Calmare Therapeutics Inc (CTTC):企業の財務・戦略的SWOT分析
    Summary Calmare Therapeutics Inc (CTI) is a bio therapeutic company that offers pain mitigation and wound care technologies. The company provides non-pharmacological, non-addictive and non-invasive solution for chronic neuropathic pain and wound care affliction patients. It offers Calmare, a pain th …
  • MediaValet Inc.:企業の戦略・SWOT・財務情報
    MediaValet Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaValet Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆